Not recruiting yet
Feasibility of Using NeuraSignal Transcranial Doppler Robot
NCT06565442 · University of Alabama at Birmingham · Updated 27 July 2026
- What is being tested
- NeuraSignal transcranial doppler robot
- For
- Cerebral Autoregulation
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 89 years. About 20 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 15 Dec 2026, ends 15 Dec 2027. Registered 22 Aug 2024.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Sites
- UAB Department of Anesthesiology and Perioperative MedicineBirmingham, Alabama, United States